RXi Pharmaceuticals Granted Patents for sd-rxRNA Technology Strengthening Intellectual Property Estate in Europe and Japan

MARLBOROUGH, Mass., Aug. 2, 2018 /PRNewswire/ — RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company developing the next generation of immuno-oncology therapeutics based on its prop…
( read original story …)


Related Post

Japan: Samurai-sharp approach delivers positive ou...
views 301
The Dh7 price point enhances Daiso’s universal app...
Property firm fined £18,000 over Japanese Knotweed...
views 50
A property owner has been fined £18,000 after allo...
‘Airbnb refugees’ in Japan seek ways a...
views 108
Asked how they planned to respond to the legal cha...
On This Day: Great Kantō earthquake strikes Japan
views 83
Sept. 1 (UPI) --On this date in history: In 1715, ...
NJPW The New Beginning In Sapporo (2/2): Kazuchika...
views 34
* Toa Henare and Manabu Nakanishi defeated Shota U...
Bank of Japan keeps easy credit stance as inflatio...
views 191
TOKYO — Japan's central bank opted Thursday to kee...
Japan’s central bank maintains rates amid Fed hike...
views 294
Japan’s central bank did not make any adjustments ...
World’s 1st Immersive “Poo Museum̶...
views 22
A world filled with poo awaits you at Yokohama's U...
China’s Xi says to maintain principle proper...
views 212
The principle was first introduced by China's top ...
Trump withdraws U.S. from TPP, raps Japan, China o...
views 295
Separately, the new Republican president accused J...